| Product Code: ETC7422068 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Guyana saw a significant increase in pregabalin import shipments, with top exporting countries being the USA, Australia, India, Ireland, and the UK. The market concentration, as measured by the HHI index, remained very high, indicating a dominant market presence by these key exporters. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was an impressive growth rate of 103.24% from 2023 to 2024, suggesting a recent surge in demand for pregabalin in Guyana. This dynamic market trend highlights the evolving landscape of pharmaceutical imports in the country.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Guyana Pregabalin Market Overview | 
| 3.1 Guyana Country Macro Economic Indicators | 
| 3.2 Guyana Pregabalin Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Guyana Pregabalin Market - Industry Life Cycle | 
| 3.4 Guyana Pregabalin Market - Porter's Five Forces | 
| 3.5 Guyana Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.6 Guyana Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F | 
| 3.7 Guyana Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Guyana Pregabalin Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of chronic pain conditions in Guyana | 
| 4.2.2 Growing awareness about the benefits of pregabalin in managing neuropathic pain | 
| 4.2.3 Rising geriatric population in Guyana requiring treatment for nerve pain | 
| 4.3 Market Restraints | 
| 4.3.1 Stringent regulatory policies impacting market entry and product approvals | 
| 4.3.2 Limited healthcare infrastructure and access to specialized pain management services in Guyana | 
| 5 Guyana Pregabalin Market Trends | 
| 6 Guyana Pregabalin Market, By Types | 
| 6.1 Guyana Pregabalin Market, By Application | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Guyana Pregabalin Market Revenues & Volume, By Application, 2021- 2031F | 
| 6.1.3 Guyana Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F | 
| 6.1.4 Guyana Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F | 
| 6.1.5 Guyana Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F | 
| 6.1.6 Guyana Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 Guyana Pregabalin Market, By Drug Class | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Guyana Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F | 
| 6.2.3 Guyana Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F | 
| 6.2.4 Guyana Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.3 Guyana Pregabalin Market, By Distribution Channel | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Guyana Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F | 
| 6.3.3 Guyana Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F | 
| 6.3.4 Guyana Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F | 
| 6.3.5 Guyana Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 Guyana Pregabalin Market Import-Export Trade Statistics | 
| 7.1 Guyana Pregabalin Market Export to Major Countries | 
| 7.2 Guyana Pregabalin Market Imports from Major Countries | 
| 8 Guyana Pregabalin Market Key Performance Indicators | 
| 8.1 Number of healthcare professionals trained in prescribing and managing pregabalin treatment | 
| 8.2 Patient satisfaction and reported pain relief after using pregabalin | 
| 8.3 Number of clinical trials and studies showcasing the efficacy of pregabalin in Guyana | 
| 9 Guyana Pregabalin Market - Opportunity Assessment | 
| 9.1 Guyana Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.2 Guyana Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F | 
| 9.3 Guyana Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Guyana Pregabalin Market - Competitive Landscape | 
| 10.1 Guyana Pregabalin Market Revenue Share, By Companies, 2024 | 
| 10.2 Guyana Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |